Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rivaroxaban versus enoxaparin for prevention of venous thromboembolism after spinal instrumentation surgery
IRCT20120527009878N16Phase 2Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Jul 2023
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in venous thromboembolism (VTE) comparing Rivaroxaban arm with Enoxaparin arm (2 arms). Primary endpoints: Inflammation, Pain and 1 more. Started Jul 2023; status: completed.
02
Drugs
rivaroxabanenoxaparin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on IRCT20120527009878N16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120527009878N16.